Department of Pathobiological Sciences, University of Wisconsin School of Veterinary Medicine, Madison, Wisconsin 53706, USA.
J Virol. 2011 Jan;85(1):530-41. doi: 10.1128/JVI.01025-10. Epub 2010 Oct 20.
Human immunodeficiency virus (HIV)-positive individuals can be superinfected with different virus strains. Individuals who control an initial HIV infection are therefore still at risk for subsequent infection with divergent viruses, but the barriers to such superinfection remain unclear. Here we tested long-term nonprogressors' (LTNPs') susceptibility to superinfection using Indian rhesus macaques that express the major histocompatibility complex class I (MHC-I) allele Mamu-B 17, which is associated with control of the pathogenic AIDS virus SIVmac239. The Mamu-B 17-restricted CD8(+) T cell repertoire is focused almost entirely on 5 epitopes. We engineered a series of SIVmac239 variants bearing mutations in 3, 4, or all 5 of these epitopes and used them to serially challenge 2 Mamu-B 17-positive LTNPs. None of the escape variants caused breakthrough replication in LTNPs, although they readily infected Mamu-B 17-negative naive macaques. In vitro competing coculture assays and examination of viral evolution in hosts lacking Mamu-B 17 suggested that the mutant viruses had negligible defects in replicative fitness. Both LTNPs maintained robust immune responses, including simian immunodeficiency virus (SIV)-specific CD8(+) and CD4(+) T cells and neutralizing antibodies. Our results suggest that escape mutations in epitopes bound by "protective" MHC-I molecules may not be sufficient to establish superinfection in LTNPs.
人类免疫缺陷病毒 (HIV) 阳性个体可能会被不同的病毒株再次感染。因此,控制初始 HIV 感染的个体仍有随后感染不同病毒的风险,但这种再次感染的障碍尚不清楚。在这里,我们使用表达主要组织相容性复合体 I 类 (MHC-I) 等位基因 Mamu-B 17 的印度猕猴来测试长期非进展者 (LTNPs) 对再次感染的易感性,Mamu-B 17 与控制致病性艾滋病病毒 SIVmac239 有关。Mamu-B 17 限制的 CD8(+) T 细胞库几乎完全集中在 5 个表位上。我们设计了一系列携带 3、4 或全部 5 个表位突变的 SIVmac239 变体,并使用它们对 2 名 Mamu-B 17 阳性 LTNPs 进行了连续挑战。尽管这些逃逸变体很容易感染 Mamu-B 17 阴性的幼稚猕猴,但它们在 LTNPs 中均未引起突破性复制。体外竞争共培养试验和缺乏 Mamu-B 17 的宿主中病毒进化的检查表明,突变病毒在复制适应性方面几乎没有缺陷。这两个 LTNPs 都保持了强大的免疫反应,包括针对 SIV 的 CD8(+) 和 CD4(+) T 细胞和中和抗体。我们的结果表明,与“保护性”MHC-I 分子结合的表位中的逃逸突变可能不足以在 LTNPs 中建立再次感染。